|
|
||||||||
Department of Human Physiology, School of Medicine, University of California, Davis, California 95616
| |
ABSTRACT |
|---|
|
|
|---|
A low K-resistant mutant Madin-Darby canine kidney (MDCK) cell line, LK-C1, has been shown previously to lack functional Na-K-Cl cotransporter (NKCC) activity, indicating that it may be a useful NKCC "knockout" cell line for structure-function studies. Using immunological probes, we first characterized the defect in the endogenous NKCC protein of the LK-C1 cells and then fully restored NKCC activity in these cells by stably expressing the human secretory NKCC1 protein (hNKCC1). The endogenous NKCC protein of the LK-C1 cells was expressed at significantly lower levels than in wild-type MDCK cells and was not properly glycosylated. This latter finding indicated that the lack of functional NKCC activity in the LK-C1 cells may be due to the inability to process the protein to the plasma membrane. In contrast, exogenously expressed hNKCC1 protein was properly processed and fully functional at the plasma membrane. Significantly, the exogenous hNKCC1 protein was regulated in a manner similar to the protein in native secretory cells as it was robustly activated by cell shrinkage, calyculin A, and low-Cl incubation. Furthermore, when the LK-C1 cells formed an epithelium on permeable supports, the exogenous hNKCC1 protein was properly polarized and functional at the basolateral membrane. The low levels of endogenous NKCC protein expression, the absence of any endogenous NKCC transport activity, and the ability to form a polarized epithelium indicate that the LK-C1 cells offer an excellent expression system with which to study the molecular physiology of the cation Cl cotransporters.
cation chloride cotransporter; secretory epithelium; polarity; Madin-Darby canine kidney cells; Na-K-Cl cotransporter
| |
INTRODUCTION |
|---|
|
|
|---|
THE CATION CHLORIDE COTRANSPORTER gene family represents a small group of transporters that function in intracellular [Cl] regulation, epithelial salt transport, and cell volume control. One member of this gene family, the Na-K-Cl cotransporter (NKCC), is represented by two separate gene products, NKCC1 and NKCC2. Whereas NKCC2 appears to be restricted in its distribution to the thick ascending limb cells of the vertebrate kidney, NKCC1 exhibits a much wider tissue expression pattern, being found in most cell types. NKCC1 expression is especially high in secretory epithelial cells where it is under significant regulatory control. Recent studies have been aimed at correlating structure and function of this transport protein (5-7). For the most part, these studies have centered on determining the sites of ion and inhibitor binding. Fewer studies have been performed on the structural aspects involved in modulation of the NKCC1 protein by conditions or agents that activate the protein. The NKCC1 protein in secretory epithelial cells as well as in duck erythrocytes is activated by cell shrinkage, by increases in cAMP, and by calyculin A (e.g., Refs. 8-10, 12, 15). Interestingly, all of these activators appear to involve increased phosphorylation of the NKCC1 protein at a common set of serine and threonine residues (8). In the shark rectal gland, three of the NKCC1 phosphorylation sites have been identified as Thr-184, Thr-189, and Thr-202 (1, 11).
In an effort to identify a useful expression system with which to pursue the molecular physiology of NKCC1 and the cation Cl cotransporter proteins in general, we undertook a study to characterize more fully a low K-resistant mutant Madin-Darby canine kidney (MDCK) cell line originally developed by McRoberts et al. (LK-C1) (14). The low K-resistant mutant MDCK cell line, LK-C1, has been previously demonstrated to have little "loop" diuretic-sensitive 86Rb, 22Na, or 36Cl uptake (<2% of control) (14). Additional studies showed that specific binding of the loop diuretic piretanide to intact LK-C1 cells was virtually undetectable (<4% of control) (2). These data strongly indicated that the LK-C1 cells were deficient in Na-K-Cl cotransport activity. In the present study, we used immunological probes to characterize further the defect of the endogenous NKCC protein of the LK-C1 cells, and then we fully restored NKCC activity by stably expressing the human secretory NKCC1 (hNKCC1) protein in these cells. The exogenously expressed hNKCC1 protein was fully functional and regulated in a manner very similar to the protein in native secretory cells. This study introduces the MDCK LK-C1 cell line as a very useful expression system for structure-function studies of the cation Cl cotransporters.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Tissue culture and stable cell line production. Both wild-type MDCK and a low K-resistant MDCK mutant were maintained in growth medium containing Dulbecco's modified Eagle's medium (DMEM), 10% fetal bovine serum, penicillin (50 U/ml), and streptomycin (50 µg/ml). The low K-resistant mutant MDCK cells (MDCK LK-C1) (14) were kindly provided by Dr. Jim McRoberts (UCLA). The T84 cells were maintained in DMEM, 5% fetal bovine serum, Ham's F-12, penicillin (50 U/ml), and streptomycin (50 µg/ml). All cells were maintained in a humidified incubator with 5% CO2 at 37°C.
hNKCC1 was stably expressed in MDCK LK-C1 cells using calcium phosphate precipitation and a previously described full-length hNKCC1 expression construct (17). After 3 wk of growth in 900 µg/ml of Geneticin (GIBCO), single resistant colonies were amplified and screened by Western blot (T4) and by bumetanide-sensitive 86Rb influx (see 86Rb influx analysis). The MDCK LK-C1 cells stably expressing hNKCC1 (MDCK LK-C1-hNKCC1) were maintained in growth media containing 900 µg/ml Geneticin. To assess the establishment of epithelial polarity, wild-type MDCK cells, MDCK LK-C1 cells, and MDCK LK-C1 cells stably expressing hNKCC1 were grown on permeable supports (0.4-µm Transwell inserts; Costar) with growth media in both upper and lower wells. Epithelial monolayers were analyzed for transepithelial resistance and potential difference using a voltohmmeter (Millipore) at various times after reaching confluency (1-4 days). The electrical resistance of the media and filter without cultured cells was subtracted from the measured values to obtain transepithelial resistance. In addition to resistance and potential difference measurements, 5-day postconfluent epithelial monolayers were analyzed for polarized activity of the Na-K-ATPase (ouabain sensitive) and NKCC (bumetanide sensitive) by 86Rb influx assay across the apical and basolateral membranes (see 86Rb influx analysis), and E-cadherin expression was analyzed by immunofluorescence (see Protein analysis).Protein analysis.
Membranes were prepared from cultured cells using differential
centrifugation. Briefly, cells were scraped off culture plates and
homogenized in 10-40 ml of homogenization buffer (250 mM sucrose, 10 mM Tris, 10 mM HEPES, and 1 mM EDTA, pH adjusted to 7.2 at 24°C)
containing protease inhibitors. After 10 strokes in a glass-Teflon homogenizer, the homogenate was centrifuged at 7,000 rpm for 10 min at
4°C (Sorval RC5, SS-34 rotor). The supernatant was centrifuged at
20,000 rpm for 30 min at 4°C. The final pellet was resuspended in
~100-500 µl of homogenization buffer with protease inhibitors and stored at
80°C. Protein concentration was determined using a
Micro BCA protein kit (Pierce, Rockford, IL). Deglycosylation of
membrane protein (20 µg) was performed by incubating membranes for
4 h at 37°C in a medium containing 0.5%
n-octylglucoside, 20 mM sodium phosphate buffer (pH 8.0), 50 mM EDTA, protease inhibitors, and N-glycosidase F (20 U/ml;
Boehringer Mannheim). Control samples were treated similarly, but
incubation was carried out in the absence of N-glycosidase
F. Enzymatic treatment was terminated by addition of electrophoresis
sample buffer. Membrane proteins were resolved by SDS-PAGE using a
7.5% Tricine gel system. Gels were electrophoretically transferred
from unstained gels to polyvinylidene difluoride (PVDF) membranes
(Immobilon P; Millipore, Bedford, MA) in transfer buffer (192 mM
glycine, 25 mM Tris-Cl, pH 8.3, and 15% methanol) for
5 h at 50 V
using a Bio-Rad Trans-Blot tank apparatus. PVDF-bound protein was
visualized by staining with Coomassie brilliant blue R-250. The PVDF
membrane was blocked in phosphate-buffered saline (PBS)-milk (7%
nonfat dry milk and 0.1% Tween 20 in PBS, pH 7.4) for 1 h and
then incubated in PBS-milk with an anti-NKCC monoclonal antibody (T4 or
T10) (13) overnight at 4°C or for 2 h at 24°C.
After three 10-min washes in PBS-milk, the PVDF membrane was incubated
with secondary antibody (horseradish peroxidase-conjugated goat
anti-mouse IgG; Amersham) for 2 h at 24°C in PBS-milk. After
three washes in PBS-0.1% Tween 20, bound antibody was detected using
an enhanced chemiluminescence assay (NEN, Boston, MA).
86Rb influx analysis. Flux experiments with MDCK cells were performed at 24°C with ~90% confluent cells grown on 96-well plates or with 5-day postconfluent cells grown on Transwell permeable supports. In contrast to our earlier expression studies with nonpolarized HEK-293 cells (16, 17), we found that bumetanide-sensitive 86Rb uptake for MDCK cells grown on 96-well plates is dramatically reduced after attainment of confluency. Although we have not investigated this finding further, it is likely related to differentiation of the MDCK cells into a polarized epithelium and the targeting of NKCC to the basolateral membrane.
96-well plate fluxes. Before flux measurement, cells were washed three times and preincubated for 15 min in control media. Control media contained 135 mM NaCl, 5 mM RbCl, 1 mM CaCl2, 1 mM MgCl2, 1 mM Na2HPO4, 2 mM Na2SO4, 3 mM glucose, and 15 mM HEPES titrated to pH 7.4 with N-methyl-D-glucamine (NMDG) base and with a final osmolarity of 290 mosmol/kgH2O. For experiments using basal conditions, cells were then incubated for an additional 15 min in control media in the presence of various drugs. For experiments using low Cl to activate NKCC, cells were incubated for an additional 40 min in low-[Cl] media. Low-[Cl] media contained 135 mM sodium methanesulfonate, 5 mM rubidium methanesulfonate, 1 mM CaCl2, 1 mM MgCl2, 1 mM Na2HPO4, 2 mM Na2SO4, 3 mM glucose, and 15 mM HEPES titrated to pH 7.4 with NMDG base and with a final osmolarity of 290 mosmol/kgH2O. Any drugs that were to be tested after low-Cl preincubation were included in the final 15 min of the low-Cl incubation period. After these various preincubations, cells were brought up in control media containing 2 µCi/ml 86RbCl, 0.1 mM ouabain, and ± 200 µM bumetanide. The bumetanide-sensitive 86Rb uptake in both wild-type MDCK cells and MDCK LK-C1 cells expressing hNKCC1 was linear for at least 8 min under either basal or low-Cl conditions, and 3- to 5-min influx assays were routinely performed to obtain initial rates (see Fig. 2). Influx of 86Rb was terminated by five washes in Tris-buffered saline (pH 7.4) containing 200 µM bumetanide. Cells were solubilized in 2% SDS and assayed for 86Rb by Cerenkov radiation and for protein by the Micro BCA method (Pierce).
The volume sensitivity of hNKCC1 activity was determined by exposing cells to isotonic, hypotonic, or hypertonic media osmotically adjusted with NMDG-methanesulfonate (MSA). All solutions contained similar final Cl concentrations (104 mM). Hypotonic media contained 95 mM NaCl, 5 mM RbCl, 1 mM CaCl2, 1 mM MgCl2, 1 mM Na2HPO4, 2 mM Na2SO4, 3 mM glucose, 15 mM HEPES titrated to pH 7.4 with NMDG base, and 0.1 mM ouabain, with a final osmolarity of 220 mosmol/kgH2O. The isotonic media contained an additional 40 mM NMDG-MSA (290 mosmol/kgH2O), and the hypertonic media contained an additional 95 mM NMDG-MSA (400 mosmol/kgH2O). Cells were preincubated for 10 min in hypotonic, isotonic, or hypertonic media before 86Rb flux analysis.Transwell fluxes. The attainment of polarity by confluent MDCK monolayers was examined by measuring the transport activity of the Na-K-ATPase (i.e., ouabain-sensitive 86Rb uptake) at the apical and basolateral membranes. Five-day postconfluent monolayers grown on permeable supports were washed twice and incubated for 15 min in control media (see above). Fresh control media (±0.1 mM ouabain) containing 2 µCi 86RbCl was then added to either the apical or basolateral compartment of the Transwell support. The opposite compartment received fresh control media containing both 0.1 mM ouabain and 10 µM bumetanide to prevent any back flux of isotope. After 6 min, filters were removed and submerged into a large volume of control media containing 0.1 mM ouabain and 10 µM bumetanide. After eight washes, filters were removed from their support and transferred to scintillation vials and lysed with 2% SDS. Isotopic decay was measured by Cerenkov radiation and protein by the Micro BCA method. For the MDCK LK-C1 cells expressing hNKCC1, we also monitored NKCC activity at the apical and basolateral membranes using a similar protocol; however, the cells were preincubated with low-[Cl] media for 60 min in both compartments to stimulate the cotransporter before flux analysis. After this preincubation, 86Rb influx was monitored as above in control media containing 0.1 mM ouabain ±10 µM bumetanide in the cis compartment. For all Transwell fluxes, a sample of the supernatant from the trans compartment was monitored for isotope as an indicator of transepithelial transport of 86Rb. In all cases, the appearance of 86Rb in the trans compartment was <0.2% of the total radioactivity in the cis compartment.
Data analysis. Results were analyzed statistically using a t-test in which experimental values were compared with control measurements. Error bars are ± SE. Statistical significance was defined as P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
NKCC protein analysis.
Using the NKCC monoclonal antibody T4, we analyzed membranes prepared
from wild-type MDCK cells, LK-C1 cells, and T84 cells by Western blot
(Fig. 1). These antibodies were prepared
against a portion of the COOH terminus of the hNKCC1 protein and
clearly recognized a single band at ~170-kDa in membranes prepared
from the human colonic T84 cell line. Upon removal of
N-linked sugar groups by treatment with
N-glycosidase F, the T4 antibody recognized a single band at
~135 kDa corresponding to the core protein deduced from the
nucleotide sequence (132 kDa) (17). Like T84 cells, wild-type MDCK cells expressed an endogenous ~170-kDa NKCC protein that was recognized by the T4 antibody, and its mobility in the gel
increased upon deglycosylation. In contrast to these two cell types,
the LK-C1 cells expressed NKCC protein that was significantly reduced
in its apparent molecular weight as well as in quantity compared with
the wild-type MDCK cells (note different protein loads). Furthermore,
the molecular weight of the NKCC protein of LK-C1 cells was only
slightly reduced by treatment of the membranes with
N-glycosidase F. These data indicate that the LK-C1 cells produce significantly less endogenous NKCC protein compared with the
wild-type MDCK cells (5- to 10-fold less) and that the protein was not
properly glycosylated. The lack of proper glycosylation of endogenous
NKCC protein in the LK-C1 cells suggested to us that the protein likely
never made it to the membrane surface and would probably be confined
largely to the endoplasmic reticulum. Immunolocalization experiments
confirmed this finding as endogenous NKCC protein of LK-C1 cells
exhibited a distinct perinuclear staining indicative of
endoplasmic reticulum labeling (data not shown). These findings are
consistent with the hypothesis that the LK-C1 cells have a defect in
the production and processing of the endogenous NKCC protein, leading
to the lack of any functional NKCC at the plasma membrane surface.
Whereas the wild-type MDCK cells exhibited a significant
bumetanide-sensitive 86Rb uptake after low-[Cl]
incubation, the LK-C1 cells displayed no such activity (Fig.
2, A and B). The
defect in the endogenous NKCC protein of the LK-C1 cells appears to be
specific because these cells have normal transport activities for the
Na-K-ATPase and Na/H exchanger (Ref. 14 and see below).
|
|
|
NKCC regulation.
The activity of the NKCC1 protein is known to be modulated by reagents
and conditions that alter its phosphorylation state. In general,
conditions that promote the phosphorylation of NKCC1 activate the protein (11, 12). We examined the
modulation of both the endogenous NKCC protein of MDCK
wild-type cells and the exogenously expressed hNKCC1 protein by
reagents known to affect the phosphorylation state and activity of
NKCC1 in secretory cells (Fig. 4,
A-E). We tested these reagents under both basal conditions and after stimulation by low-[Cl] incubation. Figure 4A illustrates that under basal conditions, exogenously
expressed hNKCC1 protein was essentially inactive because little
bumetanide-sensitive 86Rb uptake could be detected. In
direct contrast, the endogenous NKCC protein of MDCK wild-type cells
exhibited a small but significant basal flux activity that was
~10-fold higher than the exogenously expressed hNKCC1 protein in
LK-C1 cells (Fig. 4D). We hypothesized that this higher
basal flux activity of the endogenous NKCC protein was likely the
result of a higher basal phosphorylation state of the protein. In
support of this hypothesis are data from both kinase and phosphatase
inhibitors (Fig. 4, A and D). Calyculin A, a
protein phosphatase inhibitor known to lead to the increased phosphorylation and activation of NKCC1 (12), markedly
stimulated exogenously expressed hNKCC1 but only increased the activity
of the endogenous NKCC protein approximately twofold. Furthermore, the
various kinase inhibitors tested, including staurosporine and
N-ethylmaleimide (NEM), had no significant effect on the
basal activity of exogenous hNKCC1, but these reagents inhibited the basal activity of the endogenous NKCC protein of MDCK wild-type cells.
|
Establishment of a polarized epithelium with functional tight
junctions.
The LK-C1 cells represent a very useful expression system for the
cation Cl cotransporters since there is no apparent background loop diuretic-sensitive 86Rb flux activity. Furthermore,
the hNKCC1 protein appeared to be appropriately regulated when
exogenously expressed in the LK-C1 cells. An additional feature that
may be useful in cation Cl cotransporter expression experiments is the
ability of the LK-C1 cells to form a polarized epithelium. It is well
known that the wild-type MDCK cells are capable of differentiating into
a secretory-like epithelium if allowed to form confluent monolayers on
permeable supports (19). Thus we tested the ability of the
LK-C1 cells to form tight epithelial monolayers when grown on Transwell
supports. We first examined the development of transepithelial
resistance and transepithelial potential difference after the
attainment of confluency on permeable supports. As shown in Fig.
5, the wild-type MDCK cells formed a
tight epithelium 2 days after reaching confluency, with relatively high
transepithelial resistance (>1,000 ohm · cm2) and
potential difference (>20 mV). The LK-C1 cells, both control and
hNKCC1-expressing cells, exhibited significantly lower transepithelial resistances (~400 ohm · cm2) and potential
differences (~9 mV) 2-4 days after reaching confluency, but
these values still indicated that functionally intact tight junctions
had formed.
|
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
McRoberts et al. (14) developed a number of MDCK cell lines that were capable of growing under low extracellular [K] conditions following treatment of the parent cell line with the mutagen N-methyl-N'-nitro-N-nitrosoguanidine. These MDCK mutants were shown to have specific defects in the Na-K-Cl cotransport system, since they expressed reduced levels of furosemide-sensitive 22Na, 86Rb, and 36Cl influxes as well as reduced 3[H]piretanide binding but exhibited normal transport activities for the Na/H exchanger and the Na-K-ATPase (2, 14). Among the three mutant cell lines identified and characterized by McRoberts et al. (14), the LK-C1 cells were unique in that they expressed no detectable NKCC transport activity and did not exhibit any significant loop diuretic binding (2). In the absence of any functional endogenous NKCC activity, the LK-C1 cell line offers a unique system with which to examine the molecular physiology of the cation Cl cotransporters because it represents an important expression system for structure-function studies of this gene family. In the present report, we characterized both endogenous and exogenous NKCC expression in the MDCK LK-C1 cell line.
Using Western blot analysis, we found that the LK-C1 cells do express NKCC protein but at significantly lower levels than the wild-type cells (Fig. 1). Furthermore, the apparent molecular weight of the endogenous cotransporter protein was only slightly greater than the core deglycosylated mammalian NKCC1 protein (~132 kDa), indicating that the NKCC protein of the LK-C1 cells was not properly glycosylated and unlikely to be processed to the plasma membrane. This is fully consistent with the lack of specific loop diuretic binding observed by Giesen-Crouse and McRoberts (2). Immunocytochemistry confirmed that the endogenous NKCC protein of the LK-C1 cells exhibits a perinuclear staining, indicative of a protein localization in the endoplasmic reticulum. These data suggest that some defect exists in the processing of the endogenous protein, preventing its targeting to the plasma membrane. The lack of any functional NKCC protein at the plasma membrane of the LK-C1 cells was confirmed by the absence of any bumetanide-sensitive 86Rb influx (Fig. 2). Even though the LK-C1 cells have a defect in the processing of the endogenous NKCC protein, when we stably expressed the hNKCC1 protein in the LK-C1 cells, we were able to restore Na-K-Cl cotransporter activity. Thus the defect in the processing of the endogenous NKCC protein does not appear to impede the functional expression of the exogenous hNKCC1 protein. Both Western blot analysis and bumetanide-sensitive 86Rb influx assay confirmed that the exogenous hNKCC1 protein was properly glycosylated and processed to the plasma membrane (Figs. 2 and 3).
The exogenously expressed hNKCC1 in the MDCK LK-C1 cells was regulated in a manner similar to that observed in secretory tissues as well as that in MDCK wild-type cells (Fig. 4). It has been shown for a number of secretory epithelia and avian red blood cells that activation of the Na-K-Cl cotransporter involves direct phosphorylation of the protein (4, 8, 11, 20, 21). Thus the phosphorylation state of the protein reflects a competition between concurrent kinase and phosphatase activities (9). The exogenously expressed hNKCC1 protein and the endogenous NKCC protein of MDCK wild-type cells were both activated by the phosphatase inhibitor calyculin A, and their activities could be inhibited by the kinase inhibitors staurosporine and NEM. Furthermore, both NKCC proteins were activated by a low-[Cl] incubation (Fig. 4, B and E). Interestingly, the endogenous NKCC protein of MDCK wild-type cells displayed a significant basal bumetanide-sensitive 86Rb influx activity that was not observed with the exogenous hNKCC1 protein expressed in LK-C1 cells. Because the kinase inhibitors staurosporine and NEM inhibited this basal activity of the endogenous NKCC protein, we conclude that the basal phosphorylation state of the endogenous NKCC protein must be greater than that of the exogenously expressed hNKCC1 protein. We observed greater stimulation of exogenously expressed hNKCC1 under low-[Cl] conditions than with cell shrinkage. This finding is likely related to the fact that after cell shrinkage, [Cl]i increases, and this significantly inhibits full activation of the cotransporter.
The use of an MDCK cell line to express hNKCC1 has the benefit that this cell line can potentially form a functional epithelium upon differentiation. MDCK cells have been reported to be represented by two strains, a low-resistance type and a high-resistance type (18). The wild-type MDCK cells used in the present study were clearly of the high-resistance strain. We found that the MDCK LK-C1 cell line, however, does not form as tight an epithelium as the wild-type MDCK cells, but it clearly forms a polarized epithelium. When grown 5 days postconfluence on permeable supports, the MDCK LK-C1 cells expressed junctional complexes between cells as revealed by E-cadherin staining. Furthermore, the cells were appropriately polarized with functional Na-K-ATPase transport activity observed exclusively at the basolateral membrane. Interestingly, we observed that the basal Na-K-ATPase transport activity in the MDCK LK-C1 cells expressing hNKCC1 was significantly reduced from control LK-C1 cells (Fig. 7). This reduced pump activity is perplexing given that it is normal in the MDCK LK-C1 cells. It is possible that overexpression of hNKCC1 with the potent cytomegalovirus promoter used in our construct caused reduced expression of certain endogenous proteins like the Na-K-ATPase; however, we never observed any reduction in growth of the stable cells. In addition to the proper polarization of the Na-K-ATPase, we found that the exogenously expressed hNKCC1 protein exhibited functional activity exclusively at the basolateral membrane following activation by low-[Cl] incubation.
In conclusion, the MDCK LK-C1 cells exhibited many characteristics that are favorable for expression studies aimed at examining structure-function of the Na-K-Cl cotransporter. First, these cells express little endogenous NKCC protein, and the NKCC protein that is expressed is nonfunctional (i.e., not localized at the plasma membrane). Second, exogenously expressed hNKCC1 protein is regulated in a manner similar to that of secretory epithelia. Third, the cells are capable of forming a polarized epithelium that would permit independent manipulation of the apical and basolateral membranes. Because virtually all of the loop diuretic-sensitive 86Rb transport activity in the MDCK LK-C1 cells was mediated via the exogenously expressed hNKCC1 protein, these cells offer an excellent expression system for the cation Cl cotransporters and are especially useful for those cotransporters that appear to exhibit very low transport activities (e.g., K-Cl cotransporter KCC1) (3).
| |
ACKNOWLEDGEMENTS |
|---|
The authors are grateful to Jeff Williams for excellent technical assistance and to Drs. Peter Cala, Chris Lytle, Bliss Forbush III, and Martha O'Donnell for helpful discussions and readings of the manuscript. The authors are indebted to Dr. Jim McRoberts (UCLA) for providing the low K-resistant MDCK cell lines and to Dr. Bliss Forbush III (Yale University) in whose lab this work was first started.
| |
FOOTNOTES |
|---|
This work was supported by National Institutes of Health Grants DK-47661 (to B. Forbush) and National Institute of Neurological Disorders and Stroke NS-36296 (to J. A. Payne), by the University of California Davis Health Systems Research Funds (to J. A. Payne), and by a grant from the American Heart Association, Western States Affiliate (to J. A. Payne).
Address for reprint requests and other correspondence: J. A. Payne, MED: Human Physiology, One Shields Ave., Univ. of California, Davis, CA 95616-8644 (E-mail: japayne{at}ucdavis.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 12 July 2000; accepted in final form 28 December 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Behnke, RD,
and
Forbush B, III.
Stimulatory phosphorylation sites on the shark rectal gland Na-K-Cl cotransporter (Abstract).
FASEB J
12:
A1013,
1998.
2.
Giesen-Crouse, EM,
and
McRoberts JA.
Coordinate expression of piretanide receptors and Na+, K+, Cl
cotransport activity in Madin-Darby canine kidney cell mutants.
J Biol Chem
262:
17393-17397,
1987
3.
Gillen, CM,
Brill S,
Payne JA,
and
Forbush B, III.
Molecular cloning and functional expression of the K-Cl cotransport from rabbit, rat, and human: a new member of the cation-chloride cotransporter family.
J Biol Chem
271:
16237-16244,
1996
4.
Haas, M,
McBrayer D,
and
Lytle C.
[Cl
]i-dependent phosphorylation of the Na-K-Cl cotransport protein of dog tracheal epithelial cells.
J Biol Chem
270:
28955-28961,
1995
5.
Isenring, P,
and
Forbush B, III.
Ion and bumetanide binding by the Na-K-Cl cotransporter: importance of transmembrane domains.
J Biol Chem
272:
24556-24562,
1997
6.
Isenring, P,
Jacoby SC,
Chang J,
and
Forbush B, III.
Mutagenic mapping of the Na-K-Cl cotransporter for domains involved in ion transport and bumetanide binding.
J Gen Physiol
112:
549-558,
1998
7.
Isenring, P,
Jacoby SC,
and
Forbush B, III.
The role of transmembrane domain 2 in cation transport by the Na-K-Cl cotransporter.
Proc Natl Acad Sci USA
95:
7179-7184,
1998
8.
Lytle, C.
Activation of the avian erythrocyte Na-K-Cl cotransporter protein by cell shrinkage, cAMP, fluoride, and calyculin-A involves phosphorylation at common sites.
J Biol Chem
272:
15069-15077,
1997
9.
Lytle, C.
A volume-sensitive protein kinase regulates the Na-K-2Cl cotransporter in duck red blood cells.
Am J Physiol Cell Physiol
274:
C1002-C1010,
1998
10.
Lytle, C,
and
Forbush B, III.
Na-K-Cl cotransport in the shark rectal gland. II. Regulation in isolated tubules.
Am J Physiol Cell Physiol
262:
C1009-C1017,
1992
11.
Lytle, C,
and
Forbush B, III.
The Na-K-Cl cotransport protein of shark rectal gland. II. Regulation by direct phosphorylation.
J Biol Chem
267:
25438-25443,
1992
12.
Lytle, C,
and
Forbush B, III.
Regulatory phosphorylation of the secretory Na-K-Cl cotransporter: modulation by cytoplasmic Cl.
Am J Physiol Cell Physiol
270:
C437-C448,
1996
13.
Lytle, C,
Xu JC,
Biemesderfer D,
and
Forbush B, III.
Distribution and diversity of Na-K-Cl cotransport proteins: a study with monoclonal antibodies.
Am J Physiol Cell Physiol
269:
C1496-C1505,
1995
14.
McRoberts, JA,
Tran CT,
and
Saier MHJ
Characterization of low potassium-resistant mutants of the Madin-Darby canine kidney cell line with defects in NaCl/KCl symport.
J Biol Chem
258:
12320-12326,
1983
15.
Palfrey, HC,
and
Pewitt EB.
The ATP and Mg2+ dependence of Na-K-2Cl cotransport reflects a requirement for protein phosphorylation: studies using calyculin A.
Pflügers Arch
425:
321-328,
1993[Web of Science][Medline].
16.
Payne, JA.
Functional characterization of the neuronal-specific K-Cl cotransporter: implication for [K+]o regulation.
Am J Physiol Cell Physiol
273:
C1516-C1525,
1997
17.
Payne, JA,
Xu JC,
Haas M,
Lytle CY,
Ward D,
and
Forbush B, III.
Primary structure, functional expression, and chromosomal localization of the bumetanide-sensitive Na-K-Cl cotransporter in human colon.
J Biol Chem
270:
17977-17985,
1995
18.
Simmons, NL.
Ion transport in "tight" epithelial monolayers of MDCK cells.
J Membr Biol
59:
105-114,
1981[Web of Science][Medline].
19.
Simmons, NL.
Stimulation of Cl
secretion by exogenous ATP in cultured MDCK epithelial monolayers.
Biochim Biophys Acta
646:
231-242,
1981[Medline].
20.
Tanimura, A,
Kurihara K,
Reshkin SJ,
and
Turner RJ.
Involvement of direct phosphorylation in the regulation of the rat parotid Na-K-2Cl cotransporter.
J Biol Chem
270:
25252-25258,
1995
21.
Torchia, J,
Lytle C,
Pon DJ,
Forbush B, III,
and
Sen AK.
The Na-K-Cl cotransporter of avian salt gland. Phosphorylation in response to cAMP-dependent and calcium-dependent secretagogues.
J Biol Chem
267:
25444-25450,
1992
This article has been cited by other articles:
![]() |
J. R. Williams and J. A. Payne Cation transport by the neuronal K+-Cl- cotransporter KCC2: thermodynamics and kinetics of alternate transport modes Am J Physiol Cell Physiol, October 1, 2004; 287(4): C919 - C931. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Maglova, W. E. Crowe, and J. M. Russell Perinuclear localization of Na-K-Cl-cotransporter protein after human cytomegalovirus infection Am J Physiol Cell Physiol, June 1, 2004; 286(6): C1324 - C1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. de Jong, P. H.G.M. Willems, L. P.W.J. van den Heuvel, N. V.A.M. Knoers, and R. J.M. Bindels Functional Expression of the Human Thiazide-Sensitive NaCl Cotransporter in Madin-Darby Canine Kidney Cells J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2428 - 2435. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |